When should audiometry be performed versus initiating hydrochlorothiazide and triamterene therapy in a patient with Meniere disease?

Audiometry Must Be Performed First—It Is Required for Diagnosis Before Starting Any Treatment

Audiometry should be obtained when assessing a patient for Meniere disease diagnosis, and this must occur before initiating hydrochlorothiazide and triamterene therapy. The 2020 AAO-HNS guidelines explicitly state that "clinicians should obtain an audiogram when assessing a patient for the diagnosis of Ménière's disease" 1. This is not optional—audiometric documentation of low- to mid-frequency sensorineural hearing loss is a mandatory diagnostic criterion for definite Meniere disease 1.

The Diagnostic Sequence

Step 1: Obtain Baseline Audiometry

You cannot diagnose definite Meniere disease without audiometric evidence. The diagnostic criteria require 1:

• Two or more spontaneous vertigo attacks (each lasting 20 minutes to 12 hours)
• Audiometrically documented fluctuating low- to mid-frequency sensorineural hearing loss in the affected ear on at least one occasion before, during, or after a vertigo episode
• Fluctuating aural symptoms (hearing loss, tinnitus, or fullness) in the affected ear

The audiogram serves multiple critical functions:

• Establishes the diagnosis by documenting the characteristic low- to mid-frequency hearing loss pattern
• Provides baseline hearing levels for monitoring disease progression
• Differentiates definite from probable Meniere disease

Step 2: Initiate Treatment After Diagnosis

Once you have audiometric confirmation, you can proceed with medical management. The treatment hierarchy per guidelines 1 and consensus recommendations 2 is:

First-line therapy:

• Lifestyle modifications (sodium restriction <1,500 mg/day)
• Diuretics (such as hydrochlorothiazide/triamterene combination)
• Betahistine (where available)

Why This Sequence Matters

Common pitfall: Starting diuretics empirically without audiometric documentation means you cannot confirm the diagnosis of definite Meniere disease. You may be treating the wrong condition entirely—vestibular migraine, for example, presents similarly but requires different management 1.

The audiogram also establishes whether hearing is "usable" (AAO-HNS Class A/B/C) versus "nonusable" (Class D), which directly impacts later treatment decisions if medical therapy fails 1. Patients with nonusable hearing may be candidates for ablative procedures like intratympanic gentamicin or labyrinthectomy, while those with preserved hearing require hearing-preserving approaches 1.

Evidence on Diuretic Efficacy

The evidence for diuretics in Meniere disease is mixed but they remain standard first-line therapy:

• A 1986 double-blind crossover study found that Dyazide (triamterene 50 mg + hydrochlorothiazide 25 mg) significantly reduced vestibular complaints but had no significant effect on hearing or tinnitus 3
• A 2000 retrospective study showed that sodium restriction plus diuretics correlated with symptom improvement, particularly in patients with "possible" Meniere disease who had better compliance 4
• However, a 2018 systematic review concluded that the certainty of evidence for diuretics is very low, with unclear benefit for vertigo improvement or hearing preservation 5

Despite weak evidence, international consensus 2 and clinical practice guidelines 1 continue to recommend diuretics as first-line conservative therapy, likely because they are low-risk and may benefit the subset of patients with endolymphatic hydrops responsive to dehydration.

Monitoring After Treatment Initiation

Once treatment begins, the guidelines mandate ongoing audiometric monitoring: "Clinicians should document resolution, improvement, or worsening of vertigo, tinnitus, and hearing loss and any change in quality of life in patients with Ménière's disease" 1. Serial audiograms track whether hearing is stabilizing, improving, or deteriorating—critical information for determining if medical therapy is adequate or if escalation to intratympanic steroids, gentamicin, or surgery is needed.

Practical Algorithm

1. Patient presents with episodic vertigo + aural symptoms → Order audiogram immediately
2. Audiogram shows low-to-mid frequency SNHL → Diagnosis of definite Meniere disease confirmed
3. Initiate first-line therapy: Sodium restriction (<1,500 mg/day) + diuretic (e.g., HCTZ/triamterene)
4. Monitor electrolytes periodically (hypokalemia risk with thiazides) 6
5. Repeat audiogram at follow-up visits to document hearing stability or progression
6. If vertigo persists despite 3-6 months of medical therapy → Consider second-line options (intratympanic steroids) 1, 2

Never start diuretics without baseline audiometry—you need that diagnostic documentation, and you need the baseline to assess treatment response and disease progression over time.